O

OrbiMed Portfolio holdings

AUM $3.98B
This Quarter Return
+38.81%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
Cap. Flow
+$1.3B
Cap. Flow %
11.42%
Top 10 Hldgs %
37.61%
Holding
165
New
23
Increased
27
Reduced
20
Closed
17

Top Buys

1
SPRY icon
ARS Pharmaceuticals
SPRY
$405M
2
ABCL icon
AbCellera Biologics
ABCL
$338M
3
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$153M
4
UNH icon
UnitedHealth
UNH
$137M
5
PFE icon
Pfizer
PFE
$133M

Top Sells

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$315M
2
XLRN
Acceleron Pharma Inc.
XLRN
$67.6M
3
ASND icon
Ascendis Pharma
ASND
$66.4M
4
EXEL icon
Exelixis
EXEL
$58.8M
5
BIIB icon
Biogen
BIIB
$45.7M

Sector Composition

1 Healthcare 98.28%
2 Financials 0.52%
3 Technology 0.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INZY
126
DELISTED
Inozyme Pharma
INZY
$8.26M 0.07%
400,400
– –
NBTX
127
Nanobiotix
NBTX
$415M
$8.25M 0.07%
+500,000
New +$8.25M
HCAT icon
128
Health Catalyst
HCAT
$228M
$7.82M 0.07%
179,598
– –
TCRR
129
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$7.71M 0.07%
+249,279
New +$7.71M
STRO icon
130
Sutro Biopharma
STRO
$85.6M
$7.6M 0.07%
+350,000
New +$7.6M
COGT icon
131
Cogent Biosciences
COGT
$1.83B
$7.36M 0.06%
+655,000
New +$7.36M
DYN icon
132
Dyne Therapeutics
DYN
$1.92B
$7.35M 0.06%
350,000
– –
OM icon
133
Outset Medical
OM
$245M
$7.11M 0.06%
125,000
– –
XFOR icon
134
X4 Pharmaceuticals
XFOR
$70M
$6.99M 0.06%
1,086,493
– –
OBIO icon
135
Orchestra BioMed
OBIO
$147M
$6.41M 0.06%
500,000
– –
AKUS
136
DELISTED
Akouos, Inc. Common Stock
AKUS
$6.25M 0.05%
315,000
– –
EPIX icon
137
ESSA Pharma
EPIX
$11.2M
$5.49M 0.05%
460,500
-716,983
-61% -$8.55M
FDMT icon
138
4D Molecular Therapeutics
FDMT
$302M
$5.18M 0.05%
+125,000
New +$5.18M
WHWK
139
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$5.09M 0.04%
5,193,946
– –
SYBX icon
140
Synlogic
SYBX
$17.4M
$4.39M 0.04%
2,029,996
– –
FBRX icon
141
Forte Biosciences
FBRX
$138M
$3.36M 0.03%
92,200
-248,280
-73% -$9.04M
IFRX icon
142
InflaRx
IFRX
$117M
$2.8M 0.02%
556,025
-122,500
-18% -$616K
MASS icon
143
908 Devices
MASS
$199M
$2.28M 0.02%
+40,000
New +$2.28M
RNAC icon
144
Cartesian Therapeutics
RNAC
$267M
$1.63M 0.01%
539,169
-1,554,700
-74% -$4.71M
PPBT
145
Purple Biotech
PPBT
$3.76M
$1.32M 0.01%
346,197
– –
ELDN icon
146
Eledon Pharmaceuticals
ELDN
$155M
$1.11M 0.01%
73,650
-3,109,664
-98% -$1.55M
BMY.RT
147
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$276K ﹤0.01%
400,000
– –
NBRV
148
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-2,644,600
Closed -$1.41M
XLRN
149
DELISTED
Acceleron Pharma Inc.
XLRN
– –
-601,066
Closed -$67.6M
ARNA
150
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-66,700
Closed -$4.99M
3 4 5
6
7